Regeneron Pharmaceuticals (REGN) Enterprise Value (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Enterprise Value came in at -$8.8 billion in Q1 2026, down 4.84% year-on-year from -$9.2 billion in Q1 2025, and down 1.73% quarter-over-quarter from -$8.6 billion in Q4 2025.
Regeneron Pharmaceuticals has reported Enterprise Value for 18 years, with the latest figure at -$8.8 billion in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 4.84% year-over-year to -$8.8 billion; the trailing twelve-month figure through Mar 2026 stood at -$8.8 billion (down 4.84% YoY), and the FY2025 full-year result was -$8.6 billion, up 4.52% from the prior year.
- Enterprise Value for Q1 2026 stood at -$8.8 billion, down from -$8.6 billion in the prior quarter.
- The five-year high for Enterprise Value was -$7.0 billion in Q3 2022, with the low at -$10.8 billion in Q4 2023.
- Average Enterprise Value over 5 years is -$8.8 billion, with a median of -$8.8 billion recorded in 2026.
- Year-over-year, Enterprise Value plunged 101.23% in 2022 and grew 23.85% in 2025.
- Tracing REGN's Enterprise Value over 5 years: stood at -$7.7 billion in 2022, then plunged by 40.07% to -$10.8 billion in 2023, then increased by 16.9% to -$9.0 billion in 2024, then grew by 4.52% to -$8.6 billion in 2025, then declined by 1.73% to -$8.8 billion in 2026.
- The last three Enterprise Value figures came in at -$8.8 billion (Q1 2026), -$8.6 billion (Q4 2025), and -$8.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.75 Bn |
| Dec 31, 2025 | -8.61 Bn |
| Sep 30, 2025 | -8.44 Bn |
| Jun 30, 2025 | -7.47 Bn |
| Mar 31, 2025 | -8.35 Bn |
| Dec 31, 2024 | -9.01 Bn |
| Sep 30, 2024 | -9.80 Bn |
| Jun 30, 2024 | -9.81 Bn |
| Mar 31, 2024 | -10.52 Bn |
| Dec 31, 2023 | -10.84 Bn |
| Sep 30, 2023 | -9.91 Bn |
| Jun 30, 2023 | -8.93 Bn |
| Mar 31, 2023 | -8.96 Bn |
| Dec 31, 2022 | -7.74 Bn |
| Sep 30, 2022 | -7.02 Bn |
| Jun 30, 2022 | -7.57 Bn |
| Mar 31, 2022 | -7.05 Bn |
| Dec 31, 2021 | -5.69 Bn |
| Sep 30, 2021 | -5.79 Bn |
| Jun 30, 2021 | -3.91 Bn |
| Mar 31, 2021 | -3.50 Bn |
| Dec 31, 2020 | -3.59 Bn |
| Sep 30, 2020 | -3.03 Bn |
| Jun 30, 2020 | -3.14 Bn |
| Mar 31, 2020 | -4.00 Bn |
| Dec 31, 2019 | -3.21 Bn |
| Sep 30, 2019 | -2.88 Bn |
| Jun 30, 2019 | -2.67 Bn |
| Mar 31, 2019 | -3.23 Bn |
| Dec 31, 2018 | -2.81 Bn |
| Sep 30, 2018 | -2.19 Bn |
| Jun 30, 2018 | -1.68 Bn |
| Mar 31, 2018 | -1.62 Bn |
| Dec 31, 2017 | -1.41 Bn |
| Sep 30, 2017 | -1.38 Bn |
| Jun 30, 2017 | -1.27 Bn |
| Mar 31, 2017 | -1.31 Bn |
| Dec 31, 2016 | -1.04 Bn |
| Sep 30, 2016 | -1.41 Bn |
| Jun 30, 2016 | -696.51 Mn |
| Mar 31, 2016 | -849.18 Mn |
| Dec 31, 2015 | -1.05 Bn |
| Sep 30, 2015 | -895.64 Mn |
| Jun 30, 2015 | -604.25 Mn |
| Mar 31, 2015 | -742.16 Mn |
| Dec 31, 2014 | -900.48 Mn |
| Sep 30, 2014 | -1.04 Bn |
| Jun 30, 2014 | -816.91 Mn |
| Mar 31, 2014 | -648.13 Mn |
| Dec 31, 2013 | -693.98 Mn |
| Sep 30, 2013 | -445.32 Mn |
| Jun 30, 2013 | -537.51 Mn |
| Mar 31, 2013 | -307.71 Mn |
| Dec 31, 2012 | -308.10 Mn |
| Sep 30, 2012 | -262.55 Mn |
| Jun 30, 2012 | -301.02 Mn |
| Mar 31, 2012 | -432.30 Mn |
| Dec 31, 2011 | -526.94 Mn |
| Sep 30, 2011 | -245.50 Mn |
| Jun 30, 2011 | -309.68 Mn |
| Mar 31, 2011 | -226.44 Mn |
| Dec 31, 2010 | -249.37 Mn |
| Sep 30, 2010 | -479.05 Mn |
| Jun 30, 2010 | -306.34 Mn |
| Mar 31, 2010 | -117.31 Mn |
| Dec 31, 2009 | -341.33 Mn |
| Sep 30, 2009 | -250.32 Mn |
| Jun 30, 2009 | -271.47 Mn |